Control of severe portal bleeding by carrier-bound fibrin sealant

Surg Today. 2009;39(4):363-5. doi: 10.1007/s00595-008-3842-3. Epub 2009 Mar 25.

Abstract

Bleeding during liver surgery and liver transplantation (LT) can be caused by coagulation disorders, portal vein hypertension, and adhesions from previous surgical procedures. We describe here how we controlled life-threatening bleeding from a portal vein anastomosis during a third cadaveric LT, by using a carrier-bound sealant (TachoSil). This technique proved effective to control severe anastomotic portal bleeding in this situation. It represents a helpful option in the field of LT, when vascular bleeding cannot be stopped by other methods.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anastomosis, Surgical / adverse effects*
  • Drug Combinations
  • Female
  • Fibrinogen / therapeutic use*
  • Hemorrhage / etiology*
  • Hemorrhage / therapy*
  • Humans
  • Liver Transplantation*
  • Portal Vein*
  • Thrombin / therapeutic use*

Substances

  • Drug Combinations
  • TachoSil
  • Fibrinogen
  • Thrombin